Genomic & Biopharma News

Androgens more important for ovarian development, study suggests
Scientists have discovered that the male "androgen" hormone is an important element in the ovarian development of female chicken embryos, more so than in the development of male testes.
News Medical Life Sciences, 2017-03-23 14:45:19

It's not just lower U.S. drug prices Trump wants. He wants the lowest, period
It's not just lower U.S. drug prices Trump wants. He wants the lowest, period esagonowsky Thu, 03/23/2017 - 10:33
Fierce Pharma, 2017-03-23 14:33:13

Peptides target 'undruggable' prostate cancer mutation
Peptides target 'undruggable' prostate cancer mutation aalidrus Thu, 03/23/2017 - 10:16
Fierce Biotech, 2017-03-23 14:16:25

Ultragenyx under pressure as seizure drug fails phase 2 test
Ultragenyx under pressure as seizure drug fails phase 2 test phil Thu, 03/23/2017 - 10:06
Fierce Biotech, 2017-03-23 14:06:16

Warning letter follows ban for Chinese API maker Jinan Jinda Pharmaceutical
Warning letter follows ban for Chinese API maker Jinan Jinda Pharmaceutical epalmer Thu, 03/23/2017 - 10:04
Fierce Pharma, 2017-03-23 14:04:49

DNA Replication Errors Contribute to Cancer Risk
A follow-up study confirms that random mutations acquired during normal stem cell division likely play a major role in cancer incidence.
The Scientist, 2017-03-23 14:00:00

EuroBiotech Report: AstraZeneca rejection, Novartis phase 3 fail, $30M round, BioLineRx and Pierre Fabre
EuroBiotech Report: AstraZeneca rejection, Novartis phase 3 fail, $30M round, BioLineRx and Pierre Fabre nptaylor Thu, 03/23/2017 - 09:52
Fierce Biotech, 2017-03-23 13:52:52

EuroBiotech:​​​ ​​​More​​​ ​​​Articles​​​ ​​​of​​​ ​​​Note
EuroBiotech:​​​ ​​​More​​​ ​​​Articles​​​ ​​​of​​​ ​​​Note nptaylor Thu, 03/23/2017 - 09:41
Fierce Biotech, 2017-03-23 13:41:25

Sanofi on verge of $1B-plus deal for arthritis-focused biotech Flexion: source
Sanofi on verge of $1B-plus deal for arthritis-focused biotech Flexion: source aliu Thu, 03/23/2017 - 09:34
Fierce Pharma, 2017-03-23 13:34:50